Akiko Iwasaki

Akiko Iwasaki

Directeur/Membre du Conseil chez ROCHE HOLDING AG
56 ans
Health Technology
Commercial Services
Miscellaneous

Profil

Akiko Iwasaki is the founder of RIGImmune, Inc., founded in 2020.
Dr. Iwasaki is the founder of Xanadu Bio Inc., founded in 2021.
Dr. Iwasaki is the founder of PanV, Inc., founded in 2023.
Dr. Iwasaki is also the founder of Rho Bio Inc...
Dr. Iwasaki is currently Director at Genentech, Inc. Dr. Iwasaki is an Independent Non-Executive Director at Roche Holding AG since 2023.
Dr. Iwasaki is a Member at Howard Hughes Medical Institute, Inc. since 2021.
Dr. Iwasaki is a Member-Scientific Counselors at The Broad Institute, Inc. since 2023.
Dr. Iwasaki is a Professor at Yale University School of Medicine since 2011.
Dr. Iwasaki was an Advisor at 4BIO Ventures Management Ltd. Dr. Iwasaki was a Member of The American Association of Immunologists from 2018 to 2025.
Dr. Iwasaki completed undergraduate studies at the University of Toronto in 1994.
Dr. Iwasaki earned a doctorate from the University of Toronto in 1998.

Postes actifs de Akiko Iwasaki

SociétésPosteDébut
ROCHE HOLDING AG Directeur/Membre du Conseil 01/03/2023
Directeur/Membre du Conseil -
Corporate Officer/Principal 01/01/2021
Corporate Officer/Principal 01/01/2023

Anciens postes connus de Akiko Iwasaki

SociétésPosteFin
Corporate Officer/Principal 01/01/2025
Fondateur -
Fondateur -
Consultant / Advisor -
Voir l'expérience en détail de Akiko Iwasaki

Formation de Akiko Iwasaki

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

99

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Miscellaneous

Consumer Services

Commercial Services

Health Technology

Finance

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Akiko Iwasaki